Endocrine, Metabolic & Immune Disorders - Drug Targets
Title:Acknowledgement to Reviewers
Volume: 14 Issue: 4
Export Options
About this article
Cite this article as:
Acknowledgement to Reviewers, Endocrine, Metabolic & Immune Disorders - Drug Targets 2014; 14 (4) . https://dx.doi.org/10.2174/187153031404141112103009
DOI https://dx.doi.org/10.2174/187153031404141112103009 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
22
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Sympathetic and Baroreflex Function in Hypertension: Implications for Current and New Drugs
Current Pharmaceutical Design Neurotrophins' Modulation by Olive Polyphenols
Current Medicinal Chemistry Resveratrol: New Avenues for a Natural Compound in Neuroprotection
Current Pharmaceutical Design Melatonin Effects in REM Sleep Behavior Disorder Associated with Obstructive Sleep Apnea Syndrome: A Case Series
Current Alzheimer Research Direct Somatic Cell Reprogramming: Treatment of Cardiac Diseases
Current Gene Therapy Clozapine Safety, 40 Years Later
Current Drug Safety Antivirals Used for Influenza Chemoprophylaxis
Current Medicinal Chemistry Exploring Phytotherapeutic Alternatives for Obesity, Insulin Resistance and Diabetes Mellitus
Current Pharmaceutical Design Effect of Alpha-1-Acid Glycoprotein Binding on Pharmacokinetics and Pharmacodynamics
Current Drug Metabolism Indane-1,3-diones: As Potential and Selective α-glucosidase Inhibitors, their Synthesis, <i>in vitro</i> and <i>in silico</i> Studies
Medicinal Chemistry The Heme Oxygenase/Biliverdin Reductase Pathway in Drug Research and Development
Current Drug Metabolism Nanocarriers and their Actions to Improve Skin Permeability and Transdermal Drug Delivery
Current Pharmaceutical Design Tetrazoles: Synthesis and Biological Activity
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Marine Food Protection in Testicular Damages Caused by Diabetes Mellitus
Current Diabetes Reviews Meet Our Editorial Board Member
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Pharmacogenetic Study of CYP2C19 Variation and Clopidogrel Dose Adjustment According to Platelet Reactivity Monitoring in Atherothromboticrisk Patients in Thailand
Current Pharmacogenomics and Personalized Medicine Treatment of Inflammatory and Paraproteinemic Neuropathies
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Synthetic Approaches to the 2006 New Drugs
Mini-Reviews in Medicinal Chemistry Menopause and its Cardiometabolic Consequences: Current Perspectives
Current Vascular Pharmacology Application of Sustained-release Carrier of NanoAg-Epidermal Growth Factor in Promoting Refractory Diabetic Wound Healing
Letters in Drug Design & Discovery